Doktor axborotnomasi 2022, №4 (108)

Maqola mavzusi

NEUROLOGICAL MANIFESTATIONS AND COMPLICATIONS IN PATIENTS WITH CORONAVIRUS INFECTION (154-160)

Mualliflar

U. Z. Isametdinova

Muassasa

Samarkand state medical university, Samarkand, Uzbekistan

Annotatsiya

It is becoming clear that the neurological complications of COVID-19 are very common, but in some cases it is difficult to establish a causal relationship. For example, stroke may occur for reasons unrelated to coronavirus infection, while Guillain-Barré syndrome and meningoencephalitis are likely to be parainfectious. Only long-term epidemiological studies in large groups of patients allow to clarify some of these issues. This study helps to understand better the mechanisms of development of complications and develop schemes for their treatment and subsequent rehabilitation. The article presents the mechanisms of penetration of the coronavirus into the nervous system and systematizes the neurological manifestations and complications of COVID-19, which were described in the first 18 months of the pandemic. Particular attention is paid to the complications of COVID-19 in the central and peripheral nervous system, the most interesting clinical examples are given. Summing up the analysis of the literature, we can say that the clinical picture of neurological diseases and syndromes caused by coronavirus infection corresponds to the usual ideas. We also considered the assumption that SARS-CoV-2 can persist in the central nervous system for a long time in the form of inactive fragments, which means that it can recur in predisposed individuals when appropriate conditions arise. This assumption raises concerns regarding to long-term neurological complications in infected and cured patients.

Kalit so'zlar

stroke, neurological complications of COVID-19, acute myelitis, Guillain-Barré syndrome, encephalitis, COVID-19.

Adabiyotlar

1. Временные методические рекомендации Минздрава России «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Москва,2020. Версия 7 (03.06.2020)». Available from: https://static-0.rosminzdrav.ru/system/attachments/attaches/000/050/584/ original/03062020_%D0%9CR _COV ID -19_v7.pd f.[Temporary methodological recommendations of Ministry of health of Russia “Prevention, diagnosis and treat-ment of the new coronavirus infection (COVID-19). Moscow, 2020. Version 7(03.06.2020)”. Available from: https://static0. rosminzdrav.ru/system/attachments/attaches/000/050/584/original/03062020_%D0%9CR_COVID-19_v7.pdf.InRussian]. 2. А. Р. Облокулов, Г. Э. Ниёзов, Ф. Ф. Абдуллаев Клинико-патогенетическое значение нарушений гемостатического гомеостаза при новой коронавирусной инфекции (COVID-19) // Вестник врача, № 3.1 (96), 2020. С.75-78. 3. Ж. А. Ризаев, И. Р. Агабабян, С. Ш. Солеева Фенофибриновая кислота - средство для снижения инфицирования больных коронавирусом SARS-COV-2 // Вестник врача, № 4 (101), 2021. С.135-140. DOI: 10.38095/2181-466X-20211014-135-140 4. Ризаев Ж.А., Ризаев Э.А., Ахмадолиев Н.Н. Коронавирус касаллиги (COVID-19): мелатониннинг физиоло-гик таъсири нуктаи назаридан муаммонинг замонавий кўриниши // Journal of biomedicine and practice №SI (2020). – С. 7-18. http:dx.doi.org10.267392181-9300-2020-SI-1 5. Al Saiegh F, Ghosh R, Leibold A, et al. Status of SARS-CoV-2 in cerebrospinal fluid of patients withCOVID-19 and stroke [published online ahead of print, 2020 Apr 30]. J NeurolNeurosurg Psychiatry 2020; jnnp-2020-323522. 6. Alberti P, Beretta S, Piatti M, et al. GuillainBarré syndrome related to COVID-19 infection. Neurol NeuroimmunolNeuroinflamm. 2020;7(4):e741. 7. Bagheri SH, Asghari AM, Farhadi M, et al. Coincidence of COVID-19 epidemic and olfactory dysfunction out-break. medRxiv 2020. 8. Baig AM, Khaleeq A, Ali U, et al. Evidence of the COVID-19 virustargeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS ChemNeurosci. 2020;11(7):995–998. 9. Benussi A, Pilotto A, Premi E, et al. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy [published online ahead of print, 2020 May 22]. Neurology.2020;10.1212/WNL.0000000000009848. 10. Bernard-Valnet R, Pizzarotti B, Anichini A, et al. Two patients with acute meningo-encephalitis concomitant to SARS-CoV-2 infection. medRxiv 2020. 11. Beyrouti R, Adams ME, Benjamin L, et al. Characteristics of ischaemic stroke associated with COVID-19 [published online ahead of print, 2020 Apr 30]. J NeurolNeurosurg Psychiatry. 2020; jnnp-2020-323586. 12. Camdessanche JP, Morel J, Pozzetto B, et al.COVID-19 may induce Guillain-Barré syndrome. Rev Neurol (Paris). 2020;176(6):516–518. 13. Chan JF, Chan KH, Choi GK, et al. Differential cell line susceptibility to the emerging novel human betacorona-virus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation. J Infect Dis. 2013;207(11):1743–1752. 14. ChenT,WuD,Chen H, et al.Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retro-spective study [published correction appears in BMJ. 2020 Mar 31;368:m1295]. BMJ. 2020;368:m1091. 15. Deng Y, Liu W, Liu K, et al. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study. Chin Med J (Engl). 2020;133(11):1261–1267.28 том 7 №3 / 2020 Неврология / Neurology 16. Desforges M, Miletti TC, Gagnon M, et al.Activation of human monocytes after infection by human coronavirus 229E. Virus Res. 2007;130(1–2):228–240. 17. Duong L, Xu P, Liu A. Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in Downtown Los Angeles, early April 2020. Brain Behav Immun. 2020;87:33. 18. Filatov A, Sharma P, Hindi F, et al. Neurological complications of coronavirus disease (COVID-19): Encephalopathy. Cureus. 2020;12(3):e7352. 19. González-Pinto T, Luna-Rodríguez A, MorenoEstébanez A, et al. Emergency room neurology in times of COVID-19: malignant ischaemic stroke and SARS-CoV-2 infection [published online ahead of print, 2020 Apr 30]. Eur J Neurol. 2020;10.1111/ene.14286. 20. Gutiérrez-Ortiz C, Méndez A, Rodrigo-Rey S,et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19 [published online ahead of print, 2020 Apr 17]. Neurology. 2020;10.1212/WNL.0000000000009619. 21. Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382(23):2268–2270. 22. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020 Jan 30]. Lancet. 2020;395(10223):497–506. 23. Jacomy H, Fragoso G, Almazan G, et al. Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice. Virology.2006;349(2):335–346. 24. Li K, Wohlford-Lenane C, Perlman S, et al. Middle Eastrespiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. Infect Dis. 2016;213(5):712–722. 25. Li LQ, Huang T, Wang YQ, et al. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 2020;92(6):577–583. 26. Li Y. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. SSRN Electron J. 2020. 27. Li Y, Li H, Fan R, et al. Coronavirus infections in the central nervous system and respiratory tract show distinct features in hospitalized children. Intervirology. 2016;59(3):163–169. 28. Li YC, Bai WZ, Hirano N, et al. Neurotropic virus tracing suggests a membranous-coating-mediated mechanism for transsynaptic communication. J Comp Neurol. 2013;521(1):203–212. 29. LiJ, Gao J, XuYP, et al. [Expression ofsevere acute respiratory syndrome coronavirus receptors, ACE2 and CD209Lin different organ derivedmicrovascular endothelial cells]. Zhonghua Yi XueZaZhi. 2007;87(12):833–837. 30. Lodigiani C, Iapichino G, Carenzo L, et al. Venous and arterial thromboembolic complications in COVID-19 pa-tients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020;191:9–14. 31. Lushina N, Kuo JS, Shaikh HA. Pulmonary, Cerebral, and Renal Thromboembolic Disease Associated with COVID-19 Infection [published online ahead of print, 2020 Apr 23]. Radiology. 2020;201623. 32. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China [published online ahead of print, 2020 Apr 10]. JAMA Neurol. 2020;77(6):1–9. 33. Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARSCoronavirus-2. Int J Infect Dis. 2020;94:55–58. 34. Moshayedi P, Ryan TE, Mejia LLP, et al. Triage of acute ischemic stroke in confirmed COVID-19: large vessel occlusion associated with coronavirus infection. Front Neurol. 2020;11:353. 35. Netland J, Meyerholz DK, Moore S, et al. Severe acute respiratory syndrome coronavirus infection causes neu-ronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008;82(15):7264–7275. 36. Niu J, Shen L, Huang B, et al. Non-invasive bioluminescence imaging of HCoV-OC43 infection and therapy in the central nervous system of live mice. Antiviral Res. 2020;173:104646. 37. Oxley TJ, Mocco J, Majidi S, et al. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. N Engl J Med. 2020;382(20):e60. 38. Padroni M, Mastrangelo V, Asioli GM, et al. Guillain-Barré syndrome following COVID-19: new infection, old complication? [published online ahead of print, 2020 Apr 24]. J Neurol. 2020;1–3. 39. Palasca O, Santos A, Stolte C, et al. TISSUES 2.0: an integrative web resource on mammalian tissue expression [published correction appears in Database (Oxford). 2018. Jan 1;2018]. Database (Oxford). 2018;2018:bay003. 40. Pilotto A, Odolini S, Masciocchi S, et al. Steroidresponsive encephalitis in coronavirus disease 2019 [published online ahead of print, 2020 May 17].Ann Neurol.2020;10.1002/ana.25783. 41. Poyiadji N, Shahin G, Noujaim D, et al.COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features [published online ahead of print, 2020 Mar 31]. Radiology. 2020;201187. 42. Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection: A case report. J Clin Neuro-sci. 2020;76:233–235. 43. Sharifi-RazaviA, KarimiN,Rouhani N.COVID-19 and intracerebralhaemorrhage: causative or coincidental? New Microbes New Infect. 2020;35:100669. 44. Toscano G, Palmerini F, Ravaglia S, et al. GuillainBarré syndrome associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574–2576. 45. Virani A, Rabold E, Hanson T, et al. GuillainBarré syndrome associated with SARS-CoV-2 infection [published online ahead of print, 2020 Apr 18]. IDCases. 2020;20:e00771. 46. Yan CH, Faraji F, Prajapati DP, et al. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms [published online ahead of print, 2020 Apr 12]. Int Forum Allergy Rhinol. 2020;10.1002/alr.22579. 47. Ye M, Ren Y, Lv T. Encephalitis as a clinical manifestation of COVID-19 [published online ahead of print, 2020 Apr 10]. Brain Behav Immun. 2020;S0889-1591(20)30465-7. 48. Zhang Y, Xiao M, Zhang S, et al. Coagulopathy andAntiphospholipid Antibodies in Patients with Covid-19. N Engl J Med. 2020;382(17):e38. 49. Zhai P, Ding Y, Li Y. The impact of COVID-19 on ischemic stroke: a case report. Res Sq. 2020. 50. Zhao H, Shen D, Zhou H, et al. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or co-incidence? Lancet Neurol. 2020;19(5):383–384. 51. Zhao K, Huang J, Dai D, et al. Acute myelitis after SARS-CoV-2 infection: a case report. Med Rxiv 2020. 52. Zhou L, Zhang M, Wang J, et al. Sars-CoV-2: Underestimated damage to nervous system [published online ahead of print, 2020 Mar 24]. Travel Med Infect Dis.2020;101642.